Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : RHX-317
Therapeutic Area : Immunology
Study Phase : IND Enabling
Sponsor : Rheos Medicines
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The goal of the collaboration is to provide biological resources from HSC patients in order to evaluate MALT1-targeted therapeutics, including Rheos’s lead product candidate, RHX-317, for Graft-versus-Host Disease, based on functional immunologic profi...
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
October 27, 2021
Lead Product(s) : RHX-317
Therapeutic Area : Immunology
Highest Development Status : IND Enabling
Sponsor : Rheos Medicines
Deal Size : Undisclosed
Deal Type : Collaboration